9434:TSESoftBank Corp. Analysis
Data as of 2026-05-25 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
SoftBank Corp. (9434.T) is trading at ¥217.6, which sits below its 20‑day (¥221.8), 50‑day (¥218.9) and 200‑day (¥220.0) simple moving averages, indicating a short‑term price weakness. The RSI of 43.6 and a bearish MACD histogram reinforce a neutral‑to‑bearish technical outlook, while the stock remains just above the calculated support level of ¥216.6. On the fundamentals side, the company posts a solid ROE of 16.3% and a free‑cash‑flow generation of ¥1.6 trillion, yet its debt‑to‑equity ratio of 139× signals a heavy leverage load despite a sizable cash pile. Valuation metrics show a trailing P/E of 19.3 versus an industry average of 17, suggesting a modest premium, but a discounted cash‑flow fair value of ¥334.2 points to a significant upside potential. The dividend yield of 3.95% with a 76% payout ratio offers attractive income, though sustainability hinges on continued cash‑flow strength. Recent material news – the launch of a large‑scale battery business targeting AI data‑center power needs and a partnership on ultra‑light HAPS aircraft materials – adds a growth narrative that could improve margins and diversify revenue streams. Overall, the stock blends stable cash‑generating telecom operations with emerging tech initiatives, set against a low‑beta (0.06) profile and moderate 30‑day volatility of 20%.
Market Outlook
Short Term
< 1 yearKey Factors
- Price below key moving averages and bearish MACD
- Support level just above current price
- Stable volume and low beta limit downside volatility
Medium Term
1–3 yearsKey Factors
- DCF fair value indicates upside
- High dividend yield with strong cash flow
- Emerging battery and HAPS businesses could lift earnings
Long Term
> 3 yearsKey Factors
- Undervalued relative to DCF and industry peers
- Diversification into AI‑related energy storage and aerospace
- Robust free cash flow supporting dividend and debt reduction
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.